Study on drug-resistant tuberculosis
Part of Infections clinical trials.
This study looks at how tuberculosis bacteria become resistant to drugs. If you have tested positive for TB, this study might help find better treatments for resistant TB.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have tested positive for tuberculosis using a GeneXpert test.
- You can have TB in your lungs or in other parts of the body.
- You must be 12 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether TB bacteria are resistant to the drugs used for treatment. It helps doctors understand which medicines work best for newly diagnosed patients.
This study looks at the genes of tuberculosis (TB) bacteria in Central Africa to understand drug-resistant strains. If you have TB, your sample may help researchers learn more about how to treat it better.
This study tests whether using a detailed sputum test to guide treatment for drug-resistant tuberculosis (TB) leads to better outcomes. Participants' treatment is tailored based on the specific drug resistance found, which may help them recover faster and reduce side effects.
This study tracks people with tuberculosis that is mainly outside the lungs (extrapulmonary TB). It collects medical information and samples to better understand the disease and improve care. If you have this type of TB, joining could help advance knowledge and treatment.
This study uses next-generation gene testing to help manage active drug-resistant tuberculosis. It may help doctors choose the most appropriate treatment by better identifying the TB’s drug resistance.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
Hear when a new Pulmonary and Extra- Pulmonary Tuberculosis (TB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.